Target-specific drug release to the colon

被引:35
|
作者
Jain, Sanjay K. [1 ]
Jain, Anekant [1 ]
机构
[1] Dr Hari Singh Gour Vishwavidyalaya, Dept Pharmaceut Sci, Pharmaceut Res Projects Lab, Sagar 470003, MP, India
关键词
biodegradable polymers; colon delivery; colon drug delivery system; colonic microlflora;
D O I
10.1517/17425247.5.5.483
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The ability to deliver drugs to the human colon in a specific manner has become feasible over the years. Targeting pharmaceutical drugs to the colon makes it possible to achieve local or systemic drug delivery to this site. Objective: To deliver the compounds in a non-degraded form to the lower part of the gastrointestinal tract, they must first pass through the stomach and the upper part of the intestine before releasing the contents in the colon. Methods: This review provides an overview of the various approaches to targeted drug delivery to the colon using different drug delivery systems, their limitations and the future developments in this field. Results/conclusions: A microbially controlled system, which is a well-accepted approach, based on natural polymers, has the greatest potential for colonic delivery, particularly in terms of site specificity and safety. However, close attention should be paid to the performance of these products in the heterogeneous environment of the human gastrointestinal tract.
引用
下载
收藏
页码:483 / 498
页数:16
相关论文
共 50 条
  • [41] Automatic construction of target-specific sentiment lexicon
    Wu, Sixing
    Wu, Fangzhao
    Chang, Yue
    Wu, Chuhan
    Huang, Yongfeng
    EXPERT SYSTEMS WITH APPLICATIONS, 2019, 116 : 285 - 298
  • [42] Design and synthesis of target-specific contrast agents
    Dirksen, A
    Langereis, S
    de Waal, BFM
    van Genderen, MHP
    Meijer, EW
    Adriaens, W
    Hackeng, TM
    BIOPOLYMERS, 2005, 80 (04) : 514 - 514
  • [43] The target-specific oral anticoagulants: practical considerations
    Garcia, David A.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 510 - 513
  • [44] How specific are "target-specific" drugs?: Celecoxib as a case in point
    Sadee, Wolfgang
    Bohn, Laura
    MOLECULAR INTERVENTIONS, 2006, 6 (04) : 196 - 198
  • [45] Target-specific factors regulate the formation of glutamatergic transmitter release sites in cultured neocortical neurons
    Mohrmann, R
    Werner, M
    Hatt, H
    Gottmann, K
    JOURNAL OF NEUROSCIENCE, 1999, 19 (22): : 10004 - 10013
  • [46] TARGET-SPECIFIC ORAL ANTICOAGULANTS IN THE EMERGENCY DEPARTMENT
    Peacock, William Frank
    Levy, Phillip D.
    Gonzalez, Michael G.
    Than, Martin
    JOURNAL OF EMERGENCY MEDICINE, 2016, 50 (02): : 246 - 256
  • [47] Design and synthesis of target-specific contrast agents
    Dirksen, Anouk
    Langereis, Sander
    de Waal, Bas F. M.
    van Genderen, Marcel H. P.
    Meijer, E. W.
    Adriaens, Wencke
    Hackeng, Tilman M.
    UNDERSTANDING BIOLOGY USING PEPTIDES, 2006, : 675 - +
  • [48] Delivery of substances and their target-specific topical activation
    Pipkorn, Ruediger
    Waldeck, Waldemar
    Spring, Herbert
    Jenne, Juergen W.
    Braun, Klaus
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2006, 1758 (05): : 606 - 610
  • [49] Drug Targeting and Conventional Treatment of Multiple Myeloma: Analysis of Target-specific Nanotherapies in Disease Models
    Tran, Christina
    Park, Eden
    Flores, Pedro L. Rodriguez
    Campbell, Robert B.
    CURRENT DRUG THERAPY, 2022, 17 (05) : 306 - 317
  • [50] APPLICATION OF TARGET-SPECIFIC DRUG IMMUNOCONJUGATES TO EXPERIMENTAL BONE-MARROW REPLACEMENT THERAPY IN MICE
    DING, L
    YU, LZ
    XIE, SS
    GONG, DG
    VERGIDIS, R
    DIENER, E
    CANCER RESEARCH, 1990, 50 (05) : 1538 - 1543